3D Printing Stocks

[BiotechValues]

$CIMT acquisition looks like it might boost $CAMT shares which I think has been hit by shorts & low volume in last few weeks.

Don't know how accurate analyst projections are, but they're predicting a 130% increase in EPS next year with Gryphon launch, giving CAMT a forward PE of about 9 (!) if they're right. Only two analysts following it, so who knows really.

What we do know is CAMT has about .80/share in cash and can commercialize Gryphon with that + cash flow from current operations.

IF Gryphon launch is a success, I think a double from current pps in 6 months is possible.